4
Changes in Ownership
Eloxx Pharmaceuticals, Inc. Filed Acc 0001179110-11-015247
Options or other derivatives
- Director acquired 147,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Waksal Harlan · Director
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2011-11-16 | Grant or award : show line 1 in the form Common Stock Option | +147,500 | $0.20 | 2021-11-16 | 147,500 | 1,610,154 | D |
Loading xslF345X03/edgar.xml…